EverPoint Asset Management’s Idexx Laboratories IDXX Stock Holding History

EverPoint Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-100,000	Closed	-$6.41M	–	467
2015 Q2	$6.41M	Buy	+100,000	New	+$6.92M	0.12%	242

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EverPoint Asset Management's IDXX Position: Q3 2015 in Review

EverPoint Asset Management sold out of Idexx Laboratories (IDXX) in Q3 2015, closing a stake of 140,000 shares — an estimated $8.98M sold.

EverPoint Asset Management first reported a position in IDXX in Q2 2014 and held it in 3 quarters. The position peaked at $21.6M in Q1 2015. 356 funds tracked by Wall St. Rank hold IDXX as of Q3 2015.

EverPoint Asset Management reported no remaining Idexx Laboratories position as of Q3 2015 after selling out during the quarter.
EverPoint Asset Management sold 140,000 Idexx Laboratories shares in Q3 2015, an estimated $8.98M.
EverPoint Asset Management first reported a position in Idexx Laboratories in Q2 2014 and held it in 3 quarters.
EverPoint Asset Management's Idexx Laboratories position peaked at $21.6M in Q1 2015.
356 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2015.

Based on EverPoint Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.